Compare
Bridger Aerospace Group Holdings, Inc. vs DHI Group, Inc. vs SPAR Group, Inc. vs OptimizeRx Corp
| Latest fiscal year | Bridger Aerospace Group Holdings, Inc. BAER | DHI Group, Inc. DHX | SPAR Group, Inc. SGRP | OptimizeRx Corp OPRX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $122.83M | $127.83M | $136.10M | $109.43M |
| Revenue growth (YoY) | +24.6% | -9.9% | -16.8% | +18.8% |
| Gross margin | 42.1% | 84.7% (computed) | 15.9% | 67.3% |
| Operating margin | n/a | -8.9% | -12.4% | 10.7% |
| Net margin | 3.4% | -10.6% | -18.1% | 4.7% |
| Net income | $4.14M | -$13.51M | -$24.63M | $5.13M |
| EPS (Diluted) | -$0.42 | -$0.30 | -$1.04 | $0.27 |
| Operating cash flow | $16.73M | $21.10M | -$18.44M | $18.71M |
| Free cash flow | -$64.21M | $13.79M | -$21.42M | $18.66M |
| Cash & equivalents | $31.38M | $2.91M | $3.26M | $23.36M |
| Total assets | $330.31M | $188.24M | $44.06M | $176.92M |
| Total liabilities | $265.64M | $93.74M | $43.44M | $48.62M |
| Shareholders' equity | -$342.59M | $94.51M | $622.0K | $128.29M |
| Return on year-end equity | n/a | -14.3% | n/m | 4.0% |
| Shares outstanding | 55.89M | 44.46M | 24.13M | 18.76M |
Revenue, most recent five fiscal years
| Fiscal year | Bridger Aerospace Group Holdings, Inc. | DHI Group, Inc. | SPAR Group, Inc. | OptimizeRx Corp |
|---|---|---|---|---|
| Latest | $122.83M Ended 2025-12-31 | $127.83M Ended 2025-12-31 | $136.10M Ended 2025-12-31 | $109.43M Ended 2025-12-31 |
| 1 year earlier | $98.61M Ended 2024-12-31 | $141.93M Ended 2024-12-31 | $163.63M Ended 2024-12-31 | $92.13M Ended 2024-12-31 |
| 2 years earlier | $66.71M Ended 2023-12-31 | $151.88M Ended 2023-12-31 | $187.87M Ended 2023-12-31 | $71.52M Ended 2023-12-31 |
| 3 years earlier | $46.39M Ended 2022-12-31 | $149.68M Ended 2022-12-31 | $261.27M Ended 2022-12-31 | $62.45M Ended 2022-12-31 |
| 4 years earlier | n/a | $119.90M Ended 2021-12-31 | $255.72M Ended 2021-12-31 | $61.29M Ended 2021-12-31 |